Shabbir Rangwala

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir Udwadia, Pawan Singh, Hanmant Barkate et al. · International Journal of Infectious Diseases · 2020 · 291 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial

Monika Tandon, Wen Wu, Keith Moore et al. · The Lancet Regional Health - Southeast Asia · 2022 · 36 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial

Sundeep Salvi, Akash Balki, Srikanth V. Krishnamurthy et al. · ERJ Open Research · 2021 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting

Pavan Kumar Reddy, Saiprasad Patil, Akash Khobragade et al. · International Journal of General Medicine · 2022 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13